Otsuka (OTCMKTS:OTSKY) Shares Gap Down – Here’s What Happened

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKYGet Free Report) shares gapped down before the market opened on Friday . The stock had previously closed at $39.39, but opened at $38.23. Otsuka shares last traded at $38.4950, with a volume of 815 shares.

Otsuka Stock Down 2.4%

The business has a 50-day moving average price of $35.30 and a 200 day moving average price of $34.47. The company has a current ratio of 2.17, a quick ratio of 1.67 and a debt-to-equity ratio of 0.05. The stock has a market capitalization of $41.30 billion, a P/E ratio of 15.44, a P/E/G ratio of 2.76 and a beta of -0.04.

Otsuka (OTCMKTS:OTSKYGet Free Report) last announced its quarterly earnings results on Friday, July 31st. The company reported $0.70 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.19. The company had revenue of $4.41 billion for the quarter, compared to analysts’ expectations of $3.95 billion. Otsuka had a net margin of 15.50% and a return on equity of 12.93%. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. On average, equities analysts expect that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 EPS for the current fiscal year.

Otsuka Company Profile

(Get Free Report)

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.

See Also

Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.